We are live on ! Find out more
CLOV icon

Clover Health Investments

4.96 USD
+0.08
1.64%
At close Updated Nov 13, 4:00 PM EST
Pre-market
After hours
4.90
-0.06
1.21%
1 day
1.64%
5 days
1.64%
1 month
3.12%
3 months
10.47%
6 months
39.72%
Year to date
105.81%
1 year
100.81%
5 years
-34.39%
10 years
-51.37%
 

About: Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.

Employees: 724

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 31.3%
Neutral 68.8%
Negative 0%
Positive
MarketBeat
6 days ago
Clover Health Investments Sees 2027 Growth as Rival Exits New Jersey
Clover Health Investments NASDAQ: CLOV expects another year of strong membership growth in 2027, aided by a competitor's exit from its core New Jersey market and what it sees as favorable positioning for its Medicare Advantage plans, Chief Financial Officer Clay Thornton said.
Clover Health Investments Sees 2027 Growth as Rival Exits New Jersey
Neutral
Seeking Alpha
6 days ago
Clover Health Investments, Corp. (CLOV) Presents at 2026 UBS Global Healthcare Conference Transcript
Clover Health Investments, Corp. ( CLOV ) 2026 UBS Global Healthcare Conference November 9, 2026 12:30 PM EST Company Participants Clay Thornton - CFO & Principal Financial Officer Conference Call Participants Jonathan Yong - UBS Investment Bank, Research Division Presentation Jonathan Yong UBS Investment Bank, Research Division Thanks for joining us, everyone. With us today, we have Clover Health and Clay Thornton, the newly appointed CFO, moved from the interim role.
Clover Health Investments, Corp. (CLOV) Presents at 2026 UBS Global Healthcare Conference Transcript
Positive
Seeking Alpha
9 days ago
Clover Health's Best Earnings Years May Still Be Ahead
Clover Health demonstrates robust membership and revenue growth, turning GAAP profitable with improving cohort economics and operating leverage. CLOV maintains a Strong Buy rating, supported by raised 2026 guidance, a confirmed 5-star PPO rating, and a compelling risk-reward profile versus sector peers. Valuation remains attractive at a significant discount to sector medians on forward EV/sales and price-to-sales, despite rapid adjusted EBITDA growth and maturing cohorts.
Clover Health's Best Earnings Years May Still Be Ahead
Neutral
Seeking Alpha
10 days ago
Clover Health Investments, Corp. (CLOV) Q3 2026 Earnings Call Transcript
Clover Health Investments, Corp. (CLOV) Q3 2026 Earnings Call Transcript
Clover Health Investments, Corp. (CLOV) Q3 2026 Earnings Call Transcript
Positive
MarketBeat
11 days ago
What Clover Health Investments (CLOV) Said on Its Q3 Earnings Call
Clover Health Investments NASDAQ: CLOV raised the lower end of its 2026 financial guidance after reporting a third-quarter profit, and said it expects to achieve its first full year of GAAP net income profitability.
What Clover Health Investments (CLOV) Said on Its Q3 Earnings Call
Neutral
GlobeNewsWire
11 days ago
Clover Health Reports Third Quarter 2026 Results
Business Highlights: Strong third quarter performance brings year-to-date GAAP Net Income to $62 million alongside 49% year-over-year Medicare Advantage membership growth Improved Full Year 2026 guidance across all metrics 2027 AEP tracking well, with significant growth due to strong product positioning in core markets Clover's flagship PPO, representing ~98% of current membership, received a 5 Star rating for Payment Year 2028 Financial Results: Third quarter 2026 GAAP Net Income of $6 million, an improvement of $31 million year-over-year Third quarter 2026 Medicare Advantage membership of 158,907, up 45% year-over-year, and Total revenues of $759 million, up 53% year-over-year Third quarter 2026 Consolidated Gross Profit of $130 million, up 77% year-over-year, and Adjusted EBITDA of $16 million, up $14 million year-over-year Improved Full Year 2026 Guidance: Average Medicare Advantage membership of 157,000 - 158,000, representing 47% growth year-over-year at the midpoint Total revenues between $2.97 billion and $3.00 billion, representing 55% growth year-over-year at the midpoint GAAP Net Income between $25 million and $35 million Consolidated Gross Profit between $540 million and $555 million, representing 54% growth year-over-year at the midpoint Adjusted EBITDA profitability between $75 million and $85 million WILMINGTON, Del., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today reported financial results for the third quarter 2026.
Clover Health Reports Third Quarter 2026 Results
Neutral
GlobeNewsWire
20 days ago
Clover Health to Participate in Upcoming UBS Global Healthcare Conference
WILMINGTON, Del., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Interim Chief Financial Officer, Clay Thornton, will present at the 2026 UBS Global Healthcare Conference on Monday, November 9, 2026, at 12:30 p.m.
Clover Health to Participate in Upcoming UBS Global Healthcare Conference
Neutral
GlobeNewsWire
27 days ago
Clover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three States
WILMINGTON, Del., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health” or “Clover”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced that it earned top distinctions across New Jersey, Georgia, and South Carolina in U.S. News & World Report's 2027 Best Insurance Companies for Medicare Advantage (“MA”) ratings.
Clover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three States
Neutral
GlobeNewsWire
1 month ago
Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027
WILMINGTON, Del., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that the Centers for Medicare & Medicaid Services (“CMS”) has awarded its PPO Medicare Advantage (“MA”) plans a rating of 5 Stars and its HMO MA plan a rating of 4.5 Stars for 2027, which will affect payment year 2028.
Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027
Neutral
GlobeNewsWire
1 month ago
Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026
WILMINGTON, Del., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial results after the market closes on Wednesday, November 4, 2026.
Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026
Price charts implemented using Lightweight Charts™